eduKate Learning Manual
Science | Veterinary World
Confirm Stable CKD → Stage Renal Function → Substage Proteinuria and Blood Pressure → Compare With Baseline → Track Direction → Reassess the Whole Animal

Veterinary CKD Staging and Trajectory

Why the Same IRIS Stage Can Hide Two Very Different Kidney Stories

Wait, What? Two Cats Can Both Be “Stage 2” While One Is Barely Changing and the Other Is Quietly Moving

A stage is wonderfully useful because it compresses a complicated disease into a common language. But compression always leaves something out.

Imagine two cats with stable chronic kidney disease. Both currently fit the same IRIS stage. One has had almost unchanged renal markers for two years, minimal proteinuria, controlled blood pressure, stable body condition and an ordinary appetite. The other reached the same stage only recently, has rising renal markers on repeated testing, persistent proteinuria, increasing blood pressure and noticeable muscle loss.

same stage ≠ same direction ≠ same risk ≠ same lived disease.

Staging tells us where the patient is. Trajectory asks where the patient appears to be going.

The Scientific Job

This page owns one Veterinary World job:

How do veterinarians combine stable CKD stage, proteinuria, blood pressure and serial renal markers to distinguish the animal’s current kidney state from the direction and speed of change?

Veterinary Azotaemia owns localisation and interpretation of raised nitrogenous waste markers. Veterinary Urinalysis owns urine evidence. Veterinary Proteinuria owns protein loss in urine. Veterinary Blood Pressure owns pressure measurement. Veterinary Acute Kidney Injury owns rapidly changing acute renal dysfunction. This page owns the integration of stable CKD stage with longitudinal direction.

Quick Answer

IRIS staging is designed for dogs and cats with stable chronic kidney disease. It places the patient into a renal-function stage using creatinine and/or SDMA, then further characterises the case by proteinuria and systemic blood pressure. Serial measurements reveal whether that apparently stable label sits on a flat, improving, fluctuating or progressive trajectory.

The International Renal Interest Society reissued its core CKD documents as 2026 revisions. IRIS continues to stress that staging follows diagnosis of CKD and is intended for the stable patient, not an animal whose renal markers are changing rapidly over a short interval.

Explore IRIS — Current Guidelines and 2026 Revisions →

Primary Entry — First Decide Whether This Is a Stable Chronic Story

CKD staging begins only after the chronic kidney disease diagnosis is sufficiently established and short-term renal function is sufficiently stable. That qualification is easy to overlook because the word “stage” feels like a universal label.

If creatinine or SDMA is changing substantially over a short period, the animal may have acute kidney injury, acute-on-chronic disease, dehydration, changing urinary obstruction or another unstable state. Forcing that patient into a chronic stage can create false precision.

before asking “what stage?”, ask “is this patient stable enough for staging to mean what we think it means?”

Explore IRIS — Staging System and Stable-Patient Requirement →

Part 1 — A Stage Is a Coordinate, Not a Biography

IRIS staging helps veterinarians communicate a current level of renal functional impairment. It is a map coordinate. But a coordinate does not tell you the route used to reach it.

One patient may have moved slowly across years. Another may have lost substantial renal function over months and only now become stable enough to classify. A third may remain in the same stage for a long time while another disease becomes more important.

That is why the same stage can contain patients with different histories, complications and future paths.

Part 2 — Creatinine and SDMA Are Surrogate Markers, Not Direct Counts of Working Nephrons

Serum creatinine and SDMA both provide information related to renal excretory function, but neither is a direct visual count of surviving nephrons.

Creatinine is influenced by muscle mass and other patient factors. SDMA can complement creatinine because it is affected differently, which is why IRIS incorporates it into the staging framework. Yet no biomarker is perfect.

A 2026 systematic review of SDMA diagnostic accuracy in dogs and cats found marked heterogeneity among studies, variation in sensitivity and specificity and substantial uncertainty about diagnostic accuracy. That does not make SDMA useless. It means the measurement should remain inside a larger evidential picture rather than become a single-number verdict.

Explore Veterinary Record 2026 — Systematic Review of SDMA Diagnostic Accuracy →

Part 3 — Discordant Creatinine and SDMA Are a Question, Not an Error Message

Sometimes creatinine and SDMA do not place a patient neatly into the same stage. IRIS recommends interpreting discrepancies alongside factors such as muscle mass, age, breed and concurrent disease, with repeat assessment when uncertainty remains.

This is a useful reasoning habit. Disagreement between two measurements can reveal hidden assumptions. A low-muscle-mass patient may have creatinine that looks less impressive than the renal dysfunction would suggest. An unexpectedly high SDMA may require confirmation and context rather than immediate certainty.

Part 4 — Proteinuria Adds a Different Dimension of Risk

Protein in urine does not simply repeat what creatinine already told us. Persistent renal proteinuria describes another part of kidney disease: abnormal passage of protein through or handling within the nephron.

IRIS therefore substages CKD by proteinuria after pre-renal and post-renal explanations are considered. Persistence matters because a transient abnormal result and a repeatedly abnormal result do not carry the same evidential weight.

Two animals in the same renal-function stage can therefore have different proteinuria substages and different patterns of risk.

Part 5 — Blood Pressure Adds Another Axis Again

Kidney disease can alter blood-pressure regulation, and sustained hypertension can in turn damage kidneys and other target organs. IRIS therefore recommends blood-pressure substaging in CKD.

The important word is substaging. Blood pressure is not merely another way to estimate the same renal filtration stage. It describes a linked but distinct risk dimension.

stage + proteinuria + blood pressure = richer state description than stage alone.

Secondary Deepening — Trajectory Requires Repeated Measurements That Are Comparable

A trajectory is created by change across time. That sounds simple until the measurements themselves change.

Hydration status, laboratory method, muscle mass, diet, concurrent illness and sample timing can all affect renal markers. If methods or conditions change between visits, part of the apparent trend may come from measurement context rather than kidney biology.

IRIS educational guidance notes that longitudinal assessment usually provides better information than one-off evaluation and encourages trending laboratory data using consistent methodology where possible.

Explore IRIS — Creatinine, UPC and SDMA in Longitudinal Assessment →

Part 6 — “Still Stage 2” Can Conceal Meaningful Change Within the Stage

Stages are ranges, not single points. A patient can move meaningfully within a range without crossing the threshold into the next label.

If serial creatinine or SDMA is steadily rising while the patient remains technically in the same stage, that slope can matter. The stage label is unchanged; the trajectory is not.

This is a general scientific lesson: categorical labels are useful for communication, but continuous variables may reveal movement earlier.

Part 7 — Body and Muscle Condition Change the Meaning of Renal Numbers

CKD often occurs in older animals, the same population in which muscle loss can become important. A falling muscle mass can lower creatinine production and make a creatinine trend look deceptively stable or modest.

This is why the patient’s body is part of the measurement system. Renal markers should be read beside weight, body condition, muscle condition, appetite and clinical function.

eduKate Veterinary World — Body Condition and Muscle Condition

Part 8 — An Apparently “Stable” Kidney Number Can Coexist With a Changing Animal

The opposite error is possible too. A laboratory value may change little while the animal develops worsening appetite, weight loss, anaemia, hypertension, electrolyte disturbance, dehydration or reduced quality of life.

CKD is not merely a creatinine disease. It is a systemic condition whose consequences appear in the whole animal.

JC Deepening — State and Derivative Are Different Variables

Mathematically, the distinction between stage and trajectory resembles the distinction between position and rate of change.

state = where the patient is now; trajectory = how that state is changing with time.

Two patients can occupy the same position while having different derivatives. One can be nearly flat. The other can be moving quickly. That extra dimension becomes particularly important in chronic disease because clinical decisions depend not only on current impairment but also on direction, complications and remaining physiological reserve.

Part 9 — Acute-on-Chronic Change Must Not Be Hidden Inside a Chronic Stage

A dog with established CKD can still develop an acute insult. Dehydration, infection, toxins, obstruction, anaesthesia or another event may cause renal markers to move sharply away from baseline.

At that moment, the chronic stage does not disappear, but it is no longer a sufficient description of the current state. The acute change must be recognised as its own problem.

eduKate Veterinary World — Veterinary Acute Kidney Injury

Part 10 — Reclassification Is Not Failure; It Is Updated Measurement

As CKD changes, the stage and substages can change. Blood pressure or proteinuria may improve or worsen. Renal markers may cross stage boundaries. The purpose of staging is not to preserve a permanent label. It is to keep the current state legible.

A good chronic-disease record therefore preserves both the present designation and the history that produced it.

Part 11 — Progression Is Not Identical Across Dogs and Cats—or Across Individuals

CKD is heterogeneous. IRIS notes that some patients, particularly some geriatric cats, may show little progression for extended periods, while others move through stages more clearly.

This variability is precisely why a stage should never be mistaken for a clock. The label does not tell us how long the animal will remain there.

Part 12 — The Best Longitudinal Record Preserves More Than Kidney Numbers

A high-quality CKD trajectory can include serial creatinine and SDMA, urine concentrating ability, UPC, blood pressure, phosphorus, haematology, body weight, muscle condition, hydration, appetite, activity and important comorbidities.

The purpose is not to collect every possible measurement forever. It is to preserve the variables that reveal whether the kidney disease and the animal are moving in the same or different directions.

How Do We Know?

The IRIS staging framework is a consensus-based international system designed to standardise assessment and communication in canine and feline CKD. Its current guidance emphasises stable disease, creatinine and/or SDMA staging, proteinuria and blood-pressure substaging, and repeat measurements where results disagree or disease direction is uncertain.

At the same time, current evidence reminds us not to turn one biomarker into unquestioned truth. The 2026 systematic review of SDMA found substantial heterogeneity and uncertainty in diagnostic accuracy, reinforcing the value of repeated, multimodal assessment.

Observation vs Inference

Observation: a cat has stable creatinine and SDMA on repeated measurements and remains in the same IRIS stage for a year.
Inference: renal excretory function appears relatively stable over that interval; future progression is not ruled out.
Observation: another cat remains in the same stage but creatinine, SDMA and UPC rise serially while muscle condition declines.
Inference: the stage label is unchanged, but the trajectory is concerning and may be partly masked by muscle loss.
Observation: a dog with known CKD has a sudden marked creatinine rise during acute illness.
Inference: unstable acute-on-chronic dysfunction should be considered before treating the new value as a simple chronic-stage shift.

Evidence Boundaries

IRIS stage ≠ prognosis for one individual animal.
same stage ≠ same trajectory.
one creatinine result ≠ complete kidney function.
one SDMA result ≠ infallible early CKD diagnosis.
proteinuria ≠ renal protein loss until other sources are considered.
high blood pressure once ≠ persistent hypertension automatically.
stable laboratory label ≠ stable whole animal.
rapidly changing renal values ≠ appropriate CKD staging moment.

Common Misconceptions

Misconception	Better model
Stage 2 means the same disease severity for every animal.	The stage describes a renal-function range; proteinuria, pressure, body state and trajectory add important differences.
If the stage has not changed, the CKD has not changed.	Meaningful movement can occur within a stage before a threshold is crossed.
SDMA replaces creatinine.	They are complementary surrogate markers with different strengths and limitations.
A sudden renal-marker rise is simply progression.	Acute-on-chronic disease or another unstable cause may be present.

Unfamiliar Transfer

Cat A and Cat B are both classified in the same IRIS stage. Cat A has almost unchanged renal markers, no persistent proteinuria and steady body condition. Cat B has serially rising markers, persistent proteinuria, increasing systolic blood pressure and muscle loss.

A weak answer says, “They are the same stage, so they are essentially the same.” A stronger answer preserves the shared stage but recognises that their risk dimensions and trajectories are different.

Checkpoint Questions

Why should CKD staging be applied only when renal function is sufficiently stable?
What is the difference between stage and trajectory?
Why can creatinine be misleading in an animal losing muscle?
What does SDMA add, and what are its evidence limits?
Why are proteinuria and blood pressure substages rather than replacements for the main stage?
How can a patient progress while remaining in the same stage?
Why should serial measurements use comparable methods and conditions?
What is acute-on-chronic kidney dysfunction?
Why must whole-animal condition be tracked alongside kidney markers?

Answer key

Rapidly changing values may represent AKI, dehydration or another unstable state and make a chronic stage falsely precise.
Stage is the current coordinate; trajectory is the direction and speed of change.
Reduced muscle mass can reduce creatinine production.
It adds a complementary renal-function surrogate, but current diagnostic-accuracy evidence remains heterogeneous.
They describe linked but distinct risk dimensions.
Continuous values can change substantially within a categorical range.
Method and context changes can imitate biological trends.
An acute deterioration occurring in an animal with pre-existing CKD.
CKD affects and is affected by hydration, nutrition, muscle, blood pressure, anaemia and other systemic factors.

Edge Science — Can We Predict the Kidney’s Flight Path Instead of Waiting for the Next Stage?

Longitudinal nephrology is moving toward richer trajectory models: repeated creatinine and SDMA, proteinuria, blood pressure, phosphorus, body composition and other biomarkers can potentially be analysed as slopes rather than isolated thresholds.

The challenge is calibration. A model that predicts progression in one population may perform differently in another breed, age group, laboratory system or comorbidity pattern. A future system should therefore return both a forecast and the uncertainty around that forecast, while keeping the actual serial measurements visible.

Veterinary World Direction Graph

Veterinary CKD staging and trajectory → confirm chronic kidney disease → verify stability → creatinine/SDMA stage → proteinuria substage → blood-pressure substage → body/muscle context → serial trend → acute-on-chronic check → revised state → longitudinal trajectory.

Azotaemia, Urinalysis, Proteinuria, Blood Pressure and Acute Kidney Injury keep their specialised jobs. This page owns the integration of stable CKD classification with direction over time.

Research Sources and Further Reading

Educational boundary: CKD staging and monitoring guide veterinary assessment but do not determine an individual animal’s treatment or prognosis by themselves. This manual is educational and does not provide diet, medication, fluid or blood-pressure treatment instructions.

Teaching Guide for Parents, Tutors and Teachers

For the people who teach because somebody depends on them.

Draw two cars at the same point on a road. Tell the learner that Car A has been almost stationary for an hour while Car B has just arrived quickly and is still moving. Ask: “Does knowing their position tell us their direction or speed?”

confirm stable CKD → locate the current stage → add proteinuria and pressure → compare with baseline → track the slope → return to the whole animal.

The mastery target is a learner who understands why classification and change are different kinds of knowledge. A stage makes chronic kidney disease legible. A trajectory restores the time dimension that the label had to compress.

eduKate SG

eduKate Learning Manual: Veterinary CKD Staging and Trajectory | Why the Same IRIS Stage Can Hide Two Very Different Kidney Stories